BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
NCT: NCT04873037 · RECRUITING
Brief Summary
The purpose of this clinical trial is to compare the Emsella Chair therapy to Sham and to determine whether electromagnetic technology is effective in the treatment of overactive bladder (OAB). Currently there are no other studies utilizing the Emsella Chair for the treatment of OAB. Eligible subjects will receive 2 treatments per week for a total of 4 weeks.
Frequently Asked Questions
What is BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder?
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder is a clinical trial registered under NCT04873037. Current status: RECRUITING.
What is the status of NCT04873037?
The current status of NCT04873037 (BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder) is: RECRUITING.
When did BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder start?
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder started on 2021-11-22.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.